Caitlin Elizabeth Milligan, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Infectious Disease Transmission, Vertical | 5 | 2017 | 1320 | 1.080 |
Why?
|
| HIV | 3 | 2017 | 1604 | 0.980 |
Why?
|
| HIV Antibodies | 4 | 2016 | 1322 | 0.780 |
Why?
|
| Immunity, Maternally-Acquired | 2 | 2015 | 118 | 0.600 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2022 | 574 | 0.570 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2015 | 307 | 0.470 |
Why?
|
| HIV Infections | 7 | 2017 | 16718 | 0.460 |
Why?
|
| AIDS Serodiagnosis | 1 | 2014 | 184 | 0.450 |
Why?
|
| Pregnancy Complications, Infectious | 4 | 2016 | 2026 | 0.390 |
Why?
|
| Antibodies, Neutralizing | 3 | 2016 | 1978 | 0.380 |
Why?
|
| Heart Transplantation | 1 | 2023 | 3110 | 0.360 |
Why?
|
| Students | 1 | 2014 | 1654 | 0.240 |
Why?
|
| ABO Blood-Group System | 1 | 2023 | 367 | 0.190 |
Why?
|
| Policy | 1 | 2023 | 508 | 0.170 |
Why?
|
| Heart Failure | 1 | 2023 | 10900 | 0.170 |
Why?
|
| Mass Screening | 1 | 2014 | 5255 | 0.160 |
Why?
|
| Neutralization Tests | 2 | 2016 | 758 | 0.140 |
Why?
|
| Immunization, Passive | 1 | 2017 | 623 | 0.130 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2016 | 459 | 0.130 |
Why?
|
| North Carolina | 1 | 2014 | 315 | 0.120 |
Why?
|
| Infant | 5 | 2022 | 35136 | 0.110 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2014 | 224 | 0.110 |
Why?
|
| Graft Survival | 1 | 2023 | 3737 | 0.110 |
Why?
|
| Adaptive Immunity | 1 | 2017 | 713 | 0.110 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2017 | 639 | 0.110 |
Why?
|
| Condoms | 1 | 2014 | 323 | 0.100 |
Why?
|
| Anti-HIV Agents | 2 | 2017 | 4256 | 0.090 |
Why?
|
| Graft Rejection | 1 | 2023 | 4397 | 0.090 |
Why?
|
| Milk, Human | 1 | 2014 | 490 | 0.090 |
Why?
|
| Sexual Partners | 1 | 2014 | 730 | 0.090 |
Why?
|
| Breast Feeding | 2 | 2014 | 1338 | 0.090 |
Why?
|
| Universities | 1 | 2014 | 956 | 0.080 |
Why?
|
| Intensive Care Units | 1 | 2022 | 3679 | 0.080 |
Why?
|
| Length of Stay | 1 | 2022 | 6309 | 0.080 |
Why?
|
| Palliative Care | 1 | 2022 | 3493 | 0.070 |
Why?
|
| Pregnancy | 4 | 2016 | 29144 | 0.070 |
Why?
|
| Immunity, Innate | 1 | 2017 | 2958 | 0.070 |
Why?
|
| Vaccination | 1 | 2017 | 3278 | 0.070 |
Why?
|
| HIV-1 | 2 | 2013 | 6939 | 0.060 |
Why?
|
| Sexual Behavior | 1 | 2014 | 2057 | 0.060 |
Why?
|
| Health Surveys | 1 | 2014 | 4037 | 0.060 |
Why?
|
| Prodrugs | 1 | 2005 | 268 | 0.060 |
Why?
|
| Naltrexone | 1 | 2005 | 307 | 0.060 |
Why?
|
| Humans | 9 | 2023 | 744343 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2015 | 10252 | 0.050 |
Why?
|
| Narcotic Antagonists | 1 | 2005 | 562 | 0.050 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 2 | 2013 | 370 | 0.040 |
Why?
|
| Prevalence | 1 | 2014 | 15226 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2014 | 25625 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2022 | 63114 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2016 | 23338 | 0.030 |
Why?
|
| Female | 5 | 2016 | 380194 | 0.030 |
Why?
|
| Child | 1 | 2022 | 77709 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2022 | 77449 | 0.030 |
Why?
|
| Genes, env | 1 | 2012 | 95 | 0.030 |
Why?
|
| HIV Antigens | 1 | 2012 | 347 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 2013 | 1095 | 0.020 |
Why?
|
| Epitope Mapping | 1 | 2012 | 311 | 0.020 |
Why?
|
| Kenya | 1 | 2013 | 685 | 0.020 |
Why?
|
| Young Adult | 1 | 2014 | 56430 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2012 | 2839 | 0.020 |
Why?
|
| Risk Factors | 1 | 2014 | 72290 | 0.020 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2005 | 220 | 0.020 |
Why?
|
| Epitopes | 1 | 2012 | 2571 | 0.020 |
Why?
|
| Phylogeny | 1 | 2012 | 2803 | 0.020 |
Why?
|
| Solvents | 1 | 2005 | 302 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2012 | 4011 | 0.010 |
Why?
|
| Diffusion | 1 | 2005 | 833 | 0.010 |
Why?
|
| Administration, Cutaneous | 1 | 2005 | 711 | 0.010 |
Why?
|
| Acetylation | 1 | 2005 | 1085 | 0.010 |
Why?
|
| Animals | 1 | 2014 | 168757 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 1572 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 13815 | 0.010 |
Why?
|
| Adult | 1 | 2014 | 214055 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 18111 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2012 | 6544 | 0.010 |
Why?
|
| Male | 1 | 2014 | 350118 | 0.010 |
Why?
|
| Algorithms | 1 | 2005 | 13881 | 0.000 |
Why?
|